Sean F. Moran

CIK: 0001451495

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (57.1%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

CRBP
Corbus Pharmaceuticals Holdings, Inc.
Aug 7, 2026
Sale(S)
Direct
12K shares at avg. $10.08$121K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Feb 13, 2026
Sale(S)
Direct
4.7K shares at avg. $7.78$37K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jan 14, 2026
Award(A)
Direct
28.1K shares-
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 24, 2025
Sale(S)
Direct
13K shares at avg. $17.02$221K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 24, 2025
Exercise(M)
Direct
13K shares at avg. $4.26$55K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Feb 14, 2025
Sale(S)
Direct
2.8K shares at avg. $8.76$24K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jan 31, 2025
Award(A)
Direct
27.5K shares-

		Type	Shares	Price		Ownership
Aug 7, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	12,000	$10.08	$120,971	Direct
Feb 13, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	4,701	$7.78	$36,588	Direct
Jan 14, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	28,082	-	$0	Direct
Oct 24, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	12,981	$17.02	$220,937	Direct
Oct 24, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Exercise(M)	12,981	$4.26	$55,299	Direct
Feb 14, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	2,792	$8.76	$24,446	Direct
Jan 31, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	27,500	-	-	Direct

1-7 of 7 transactions

About Moran Sean F.

Moran Sean F. (SEC CIK 0001451495) files insider reports with the SEC as Chief Financial Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP).

Signal8 holds 6 ownership filings by Moran Sean F., all Form 4s, filed between Feb 4, 2025 and Aug 10, 2026. Those filings report 7 transactions, from Jan 31, 2025 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Moran Sean F.'s filings is in NORWOOD, MA.

Recent filings by Moran Sean F.

Aug 7, 2026: Open-market sale of CRBP shares (Form 4, code S).
Feb 13, 2026: Open-market sale of CRBP shares (Form 4, code S).
Jan 14, 2026: Grant or award of CRBP shares (Form 4, code A).
Oct 24, 2025: Open-market sale of CRBP shares (Form 4, code S).
Oct 24, 2025: Option exercise of CRBP shares (Form 4, code M).

Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Cormorant Asset Management, LP, Officer
Ben Yong, Director
Nicacio Leonardo Viana, Chief Medical Officer
Saxena Nishant C, Chief Business Officer
Cohen Yuval, Chief Executive Officer
Kung Winston, Director

How to read Form 4 transaction codes